APO RESEARCH · REPORT
Oral Health Supplements
Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.
Product & engineering
Understand the product.
Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.
Formulation strategy is mechanism-led. Microbiome-directed designs use strain-identified probiotics or postbiotics with optional prebiotic substrates to suppress cariogenic and periodontopathogenic taxa, inhibit adhesion and co-aggregation, and stabilize intra-oral pH; dosage forms prioritize residence time through lozenges, gums, or thin films to maximize mucosal contact. Remineralization support raises salivary calcium-phosphate supersaturation and buffering capacity using bioavailable calcium and phosphate sources co-formulated with vitamin D and, where appropriate, vitamin K₂; arginine or xylitol may be included to leverage the arginine deiminase pathway and non-fermentable sweetening. Anti-inflammatory and antioxidant complexes, typically combining omega-3 EPA/DHA, coenzyme Q10, zinc, vitamin C, and selected polyphenols, aim to temper local mediators and support collagen synthesis in periodontal tissues. Halitosis control relies on odor-binding ions such as zinc and compatible microbiome modulators to reduce volatile sulfur compounds measured instrumentally.
Dosage-form engineering determines clinical yield. Orodispersible and mucoadhesive matrices based on HPMC, polycarbophil, or carbomers are tuned for wetting, controlled erosion, and adhesion to non-keratinized mucosa; oromucosal films are cast for uniform content, defined tear strength, and disintegration within targeted residence windows. Probiotic viability is protected through low-water-activity systems, glass-forming carriers, and oxygen control, with viable counts specified at end-of-shelf-life rather than at manufacture. Flavor and sweetening systems are chosen for dental compatibility, favoring xylitol or mannitol over fermentable sugars; compression, lubrication, and moisture management are balanced to prevent capping and to maintain friability in lozenges. Delivery performance is verified with appropriate disintegration and dissolution testing, residence-time studies in model saliva, and, for gums, mass-balance release methods.
Ingredient quality is defined to pharmacopeial or validated internal standards. Vitamins and minerals are declared by chemical form and potency; omega-3 concentrates specify EPA+DHA content together with oxidation indices; polyphenol sources are fingerprinted for marker compounds and screened for adulteration; probiotics are identified to strain by genetic or proteomic methods with contaminant screening and, where relevant, antibiotic-resistance profiling. Elemental contaminants such as arsenic, cadmium, lead, and mercury are controlled to stringent limits; microbial quality follows non-sterile supplement specifications with absence testing for relevant pathogens. Allergen and excipient declarations reflect regional labeling rules, including potential dairy or soy carriers in probiotic systems.
Manufacturing operates under current good manufacturing practice for dietary supplements. Quality-unit oversight, master manufacturing records with controlled changes, supplier qualification and full material traceability, validated analytical methods, in-process controls, and finished-product specifications for identity, strength, purity, and composition are mandatory. Out-of-specification investigations and corrective-and-preventive actions precede quality disposition. Stability programs combine accelerated and real-time studies to justify expiry; acceptance criteria cover potency retention, viable counts where applicable, organoleptics, and microbiological status. Packaging is selected for moisture and oxygen barrier performance appropriate to climate risk—Alu–Alu blisters, induction-sealed HDPE with desiccant canisters, or composite pouches with scavengers—supported by sorbent sizing calculations and transit simulations.
Claims, labeling, and surveillance are designed into the product at concept stage. In the United States, products carry substantiated structure/function claims such as “supports healthy gums,” bear the dietary-supplement disclaimer, and maintain serious adverse-event reporting; disease claims are excluded. In the European Union, supplements are defined under food-supplement law and all nutrition and health claims use authorized or qualified wording; novel ingredients may require novel-food clearance. In China, the category is managed as health foods with registration or filing and defined function catalogues; in Japan, many products follow FOSHU or Foods with Function Claims routes with pre-market notification and public evidence summaries. Across markets, truthful labeling, transparent quantitation of actives, and documented claim substantiation are baseline expectations for market access and enforcement resilience.
Clinical evaluation follows dental research standards and treats the product as an adjunct to hygiene and recall protocols. Primary endpoints include plaque indices and composition, salivary pH and buffering capacity, counts of Streptococcus mutans and key anaerobes, bleeding on probing and gingival indices, pocket-depth trends in maintenance cohorts, enamel surface microhardness or early-lesion arrest, and instrumented volatile sulfur compound reduction. Selected trials incorporate 16S rRNA profiling or qPCR for microbiome shifts, gas chromatography or electrochemical sensors for halitosis, quantitative light-induced fluorescence for demineralization assessment, and standardized diet controls to reduce confounding. Expected effect sizes are modest but clinically relevant when mechanism and dosage form match the risk phenotype and adherence is maintained.
Selection and procurement are mechanism- and form-led. Mucosal-contact formats are prioritized for microbiome modulation and halitosis control, while capsules and powders are efficient for mineral availability and systemic inflammatory tone. Labels declare probiotic colony-forming units at end-of-shelf-life with strain identifiers, mineral systems specify calcium and phosphate sources together with vitamin D and optional K₂, and omega-3 complexes state daily EPA+DHA equivalents and oxidation limits. Professional buyers request lot-level certificates of analysis referencing methods for potency and contaminants, stability evidence to labeled expiry under stated storage, and clinical substantiation packages aligning endpoints with labeled claims. Shipping and storage conditions are predefined, including temperature and humidity tolerances and allowable excursions.
Use and safety follow responsible supplementation principles. Dosing adheres to labeled instructions and age appropriateness; nutrient–drug interactions such as vitamin K with anticoagulants and high-dose zinc with copper balance are considered; probiotics are used cautiously in severely immunocompromised individuals. Allergen, pregnancy and lactation, and pediatric guidance is explicit. Products are integrated into regimens that include brushing, interdental cleaning, topical fluoride where indicated, diet counseling, and regular professional hygiene, and they are not positioned as substitutes for definitive periodontal or restorative therapies.
Selected research
Market Analysis & Forecast
Global Oral Health Supplements Market Analysis and Forecast 2026-2032
Market perspective
Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone. Topical cosmetics such as toothpastes and rinses are outside scope, and fluoride drugs or any product asserting disease treatment are regulated separately. In all major jurisdictions these products are governed under dietary or health-food frameworks with structure/function positioning and post-market surveillance rather than pre-market drug approval.
Formulation strategy is mechanism-led. Microbiome-directed designs use strain-identified probiotics or postbiotics with optional prebiotic substrates to suppress cariogenic and periodontopathogenic taxa, inhibit adhesion and co-aggregation, and stabilize intra-oral pH; dosage forms prioritize residence time through lozenges, gums, or thin films to maximize mucosal contact. Remineralization support raises salivary calcium-phosphate supersaturation and buffering capacity using bioavailable calcium and phosphate sources co-formulated with vitamin D and, where appropriate, vitamin K₂; arginine or xylitol may be included to leverage the arginine deiminase pathway and non-fermentable sweetening. Anti-inflammatory and antioxidant complexes, typically combining omega-3 EPA/DHA, coenzyme Q10, zinc, vitamin C, and selected polyphenols, aim to temper local mediators and support collagen synthesis in periodontal tissues. Halitosis control relies on odor-binding ions such as zinc and compatible microbiome modulators to reduce volatile sulfur compounds measured instrumentally.
Dosage-form engineering determines clinical yield. Orodispersible and mucoadhesive matrices based on HPMC, polycarbophil, or carbomers are tuned for wetting, controlled erosion, and adhesion to non-keratinized mucosa; oromucosal films are cast for uniform content, defined tear strength, and disintegration within targeted residence windows. Probiotic viability is protected through low-water-activity systems, glass-forming carriers, and oxygen control, with viable counts specified at end-of-shelf-life rather than at manufacture. Flavor and sweetening systems are chosen for dental compatibility, favoring xylitol or mannitol over fermentable sugars; compression, lubrication, and moisture management are balanced to prevent capping and to maintain friability in lozenges. Delivery performance is verified with appropriate disintegration and dissolution testing, residence-time studies in model saliva, and, for gums, mass-balance release methods.
Read the full market overview
Ingredient quality is defined to pharmacopeial or validated internal standards. Vitamins and minerals are declared by chemical form and potency; omega-3 concentrates specify EPA+DHA content together with oxidation indices; polyphenol sources are fingerprinted for marker compounds and screened for adulteration; probiotics are identified to strain by genetic or proteomic methods with contaminant screening and, where relevant, antibiotic-resistance profiling. Elemental contaminants such as arsenic, cadmium, lead, and mercury are controlled to stringent limits; microbial quality follows non-sterile supplement specifications with absence testing for relevant pathogens. Allergen and excipient declarations reflect regional labeling rules, including potential dairy or soy carriers in probiotic systems.
Manufacturing operates under current good manufacturing practice for dietary supplements. Quality-unit oversight, master manufacturing records with controlled changes, supplier qualification and full material traceability, validated analytical methods, in-process controls, and finished-product specifications for identity, strength, purity, and composition are mandatory. Out-of-specification investigations and corrective-and-preventive actions precede quality disposition. Stability programs combine accelerated and real-time studies to justify expiry; acceptance criteria cover potency retention, viable counts where applicable, organoleptics, and microbiological status. Packaging is selected for moisture and oxygen barrier performance appropriate to climate risk—Alu–Alu blisters, induction-sealed HDPE with desiccant canisters, or composite pouches with scavengers—supported by sorbent sizing calculations and transit simulations.
Claims, labeling, and surveillance are designed into the product at concept stage. In the United States, products carry substantiated structure/function claims such as “supports healthy gums,” bear the dietary-supplement disclaimer, and maintain serious adverse-event reporting; disease claims are excluded. In the European Union, supplements are defined under food-supplement law and all nutrition and health claims use authorized or qualified wording; novel ingredients may require novel-food clearance. In China, the category is managed as health foods with registration or filing and defined function catalogues; in Japan, many products follow FOSHU or Foods with Function Claims routes with pre-market notification and public evidence summaries. Across markets, truthful labeling, transparent quantitation of actives, and documented claim substantiation are baseline expectations for market access and enforcement resilience.
Clinical evaluation follows dental research standards and treats the product as an adjunct to hygiene and recall protocols. Primary endpoints include plaque indices and composition, salivary pH and buffering capacity, counts of Streptococcus mutans and key anaerobes, bleeding on probing and gingival indices, pocket-depth trends in maintenance cohorts, enamel surface microhardness or early-lesion arrest, and instrumented volatile sulfur compound reduction. Selected trials incorporate 16S rRNA profiling or qPCR for microbiome shifts, gas chromatography or electrochemical sensors for halitosis, quantitative light-induced fluorescence for demineralization assessment, and standardized diet controls to reduce confounding. Expected effect sizes are modest but clinically relevant when mechanism and dosage form match the risk phenotype and adherence is maintained.
Selection and procurement are mechanism- and form-led. Mucosal-contact formats are prioritized for microbiome modulation and halitosis control, while capsules and powders are efficient for mineral availability and systemic inflammatory tone. Labels declare probiotic colony-forming units at end-of-shelf-life with strain identifiers, mineral systems specify calcium and phosphate sources together with vitamin D and optional K₂, and omega-3 complexes state daily EPA+DHA equivalents and oxidation limits. Professional buyers request lot-level certificates of analysis referencing methods for potency and contaminants, stability evidence to labeled expiry under stated storage, and clinical substantiation packages aligning endpoints with labeled claims. Shipping and storage conditions are predefined, including temperature and humidity tolerances and allowable excursions.
Use and safety follow responsible supplementation principles. Dosing adheres to labeled instructions and age appropriateness; nutrient–drug interactions such as vitamin K with anticoagulants and high-dose zinc with copper balance are considered; probiotics are used cautiously in severely immunocompromised individuals. Allergen, pregnancy and lactation, and pediatric guidance is explicit. Products are integrated into regimens that include brushing, interdental cleaning, topical fluoride where indicated, diet counseling, and regular professional hygiene, and they are not positioned as substitutes for definitive periodontal or restorative therapies.
The global Oral Health Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Health Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oral Health Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Oral Health Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oral Health Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Oral Health Supplements include BioGaia AB, Sunstar Suisse SA, Life Extension, Swisse Wellness, NOW Foods, Kaneka AB-Biotics, Blis Technologies, WonderLab and Hyperbiotics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Health Supplements, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oral Health Supplements, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Health Supplements, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Health Supplements sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Health Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Health Supplements sales, projected growth trends, production technology, application and end-user industry.
Oral Health Supplements Segment by Company
BioGaia AB
Sunstar Suisse SA
Life Extension
Swisse Wellness
NOW Foods
Kaneka AB-Biotics
Blis Technologies
WonderLab
Hyperbiotics
Hager Pharma
ProBiora Health
JEX Co., Ltd
Dentis Co., Ltd
Oral Health Supplements Segment by Type
Lozenges
Drops
Powder
Strips and Gums
Oral Health Supplements Segment by Application
Daily Care
Perio Adjunct
Halitosis
Caries and Orthodontic
Xerostomia
Oral Health Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Health Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Health Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Health Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oral Health Supplements in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oral Health Supplements manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Health Supplements sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lozenges
- Drops
- Powder
- Strips and Gums
Applications
- Daily Care
- Perio Adjunct
- Halitosis
- Caries and Orthodontic
- Xerostomia
Companies covered
- BioGaia AB
- Sunstar Suisse SA
- Life Extension
- Swisse Wellness
- NOW Foods
- Kaneka AB-Biotics
- Blis Technologies
- WonderLab
- Hyperbiotics
- Hager Pharma
- ProBiora Health
- JEX Co., Ltd
- Dentis Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oral Health Supplements Market by Type
- 1.2.1 Global Oral Health Supplements Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Lozenges
- 1.2.3 Drops
- 1.2.4 Powder
- 1.2.5 Strips and Gums
- 1.3 Oral Health Supplements Market by Application
- 1.3.1 Global Oral Health Supplements Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Daily Care
- 1.3.3 Perio Adjunct
- 1.3.4 Halitosis
- 1.3.5 Caries and Orthodontic
- 1.3.6 Xerostomia
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oral Health Supplements Market Dynamics
- 2.1 Oral Health Supplements Industry Trends
- 2.2 Oral Health Supplements Industry Drivers
- 2.3 Oral Health Supplements Industry Opportunities and Challenges
- 2.4 Oral Health Supplements Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Oral Health Supplements Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Oral Health Supplements Revenue by Region
- 3.2.1 Global Oral Health Supplements Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oral Health Supplements Revenue by Region (2021-2026)
- 3.2.3 Global Oral Health Supplements Revenue by Region (2027-2032)
- 3.2.4 Global Oral Health Supplements Revenue Market Share by Region (2021-2032)
- 3.3 Global Oral Health Supplements Sales Estimates and Forecasts 2021-2032
- 3.4 Global Oral Health Supplements Sales by Region
- 3.4.1 Global Oral Health Supplements Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Oral Health Supplements Sales by Region (2021-2026)
- 3.4.3 Global Oral Health Supplements Sales by Region (2027-2032)
- 3.4.4 Global Oral Health Supplements Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oral Health Supplements Revenue by Manufacturers
- 4.1.1 Global Oral Health Supplements Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Oral Health Supplements Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Oral Health Supplements Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oral Health Supplements Sales by Manufacturers
- 4.2.1 Global Oral Health Supplements Sales by Manufacturers (2021-2026)
- 4.2.2 Global Oral Health Supplements Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Oral Health Supplements Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Oral Health Supplements Sales Price by Manufacturers (2021-2026)
- 4.4 Global Oral Health Supplements Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Oral Health Supplements Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oral Health Supplements Manufacturers, Product Type & Application
- 4.7 Global Oral Health Supplements Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oral Health Supplements Market CR5 and HHI
- 4.8.2 2025 Oral Health Supplements Tier 1, Tier 2, and Tier 3
5 Oral Health Supplements Market by Type
- 5.1 Global Oral Health Supplements Revenue by Type
- 5.1.1 Global Oral Health Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Oral Health Supplements Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Oral Health Supplements Revenue Market Share by Type (2021-2032)
- 5.2 Global Oral Health Supplements Sales by Type
- 5.2.1 Global Oral Health Supplements Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Health Supplements Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Oral Health Supplements Sales Market Share by Type (2021-2032)
- 5.3 Global Oral Health Supplements Price by Type
6 Oral Health Supplements Market by Application
- 6.1 Global Oral Health Supplements Revenue by Application
- 6.1.1 Global Oral Health Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Oral Health Supplements Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Oral Health Supplements Revenue Market Share by Application (2021-2032)
- 6.2 Global Oral Health Supplements Sales by Application
- 6.2.1 Global Oral Health Supplements Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Oral Health Supplements Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Oral Health Supplements Sales Market Share by Application (2021-2032)
- 6.3 Global Oral Health Supplements Price by Application
7 Company Profiles
- 7.1 BioGaia AB
- 7.1.1 BioGaia AB Company Information
- 7.1.2 BioGaia AB Business Overview
- 7.1.3 BioGaia AB Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 BioGaia AB Oral Health Supplements Product Portfolio
- 7.1.5 BioGaia AB Recent Developments
- 7.2 Sunstar Suisse SA
- 7.2.1 Sunstar Suisse SA Company Information
- 7.2.2 Sunstar Suisse SA Business Overview
- 7.2.3 Sunstar Suisse SA Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sunstar Suisse SA Oral Health Supplements Product Portfolio
- 7.2.5 Sunstar Suisse SA Recent Developments
- 7.3 Life Extension
- 7.3.1 Life Extension Company Information
- 7.3.2 Life Extension Business Overview
- 7.3.3 Life Extension Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Life Extension Oral Health Supplements Product Portfolio
- 7.3.5 Life Extension Recent Developments
- 7.4 Swisse Wellness
- 7.4.1 Swisse Wellness Company Information
- 7.4.2 Swisse Wellness Business Overview
- 7.4.3 Swisse Wellness Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Swisse Wellness Oral Health Supplements Product Portfolio
- 7.4.5 Swisse Wellness Recent Developments
- 7.5 NOW Foods
- 7.5.1 NOW Foods Company Information
- 7.5.2 NOW Foods Business Overview
- 7.5.3 NOW Foods Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 NOW Foods Oral Health Supplements Product Portfolio
- 7.5.5 NOW Foods Recent Developments
- 7.6 Kaneka AB-Biotics
- 7.6.1 Kaneka AB-Biotics Company Information
- 7.6.2 Kaneka AB-Biotics Business Overview
- 7.6.3 Kaneka AB-Biotics Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Kaneka AB-Biotics Oral Health Supplements Product Portfolio
- 7.6.5 Kaneka AB-Biotics Recent Developments
- 7.7 Blis Technologies
- 7.7.1 Blis Technologies Company Information
- 7.7.2 Blis Technologies Business Overview
- 7.7.3 Blis Technologies Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Blis Technologies Oral Health Supplements Product Portfolio
- 7.7.5 Blis Technologies Recent Developments
- 7.8 WonderLab
- 7.8.1 WonderLab Company Information
- 7.8.2 WonderLab Business Overview
- 7.8.3 WonderLab Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 WonderLab Oral Health Supplements Product Portfolio
- 7.8.5 WonderLab Recent Developments
- 7.9 Hyperbiotics
- 7.9.1 Hyperbiotics Company Information
- 7.9.2 Hyperbiotics Business Overview
- 7.9.3 Hyperbiotics Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Hyperbiotics Oral Health Supplements Product Portfolio
- 7.9.5 Hyperbiotics Recent Developments
- 7.10 Hager Pharma
- 7.10.1 Hager Pharma Company Information
- 7.10.2 Hager Pharma Business Overview
- 7.10.3 Hager Pharma Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Hager Pharma Oral Health Supplements Product Portfolio
- 7.10.5 Hager Pharma Recent Developments
- 7.11 ProBiora Health
- 7.11.1 ProBiora Health Company Information
- 7.11.2 ProBiora Health Business Overview
- 7.11.3 ProBiora Health Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 ProBiora Health Oral Health Supplements Product Portfolio
- 7.11.5 ProBiora Health Recent Developments
- 7.12 JEX Co., Ltd
- 7.12.1 JEX Co., Ltd Company Information
- 7.12.2 JEX Co., Ltd Business Overview
- 7.12.3 JEX Co., Ltd Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 JEX Co., Ltd Oral Health Supplements Product Portfolio
- 7.12.5 JEX Co., Ltd Recent Developments
- 7.13 Dentis Co., Ltd
- 7.13.1 Dentis Co., Ltd Company Information
- 7.13.2 Dentis Co., Ltd Business Overview
- 7.13.3 Dentis Co., Ltd Oral Health Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Dentis Co., Ltd Oral Health Supplements Product Portfolio
- 7.13.5 Dentis Co., Ltd Recent Developments
8 North America
- 8.1 North America Oral Health Supplements Market Size by Type
- 8.1.1 North America Oral Health Supplements Revenue by Type (2021-2032)
- 8.1.2 North America Oral Health Supplements Sales by Type (2021-2032)
- 8.1.3 North America Oral Health Supplements Price by Type (2021-2032)
- 8.2 North America Oral Health Supplements Market Size by Application
- 8.2.1 North America Oral Health Supplements Revenue by Application (2021-2032)
- 8.2.2 North America Oral Health Supplements Sales by Application (2021-2032)
- 8.2.3 North America Oral Health Supplements Price by Application (2021-2032)
- 8.3 North America Oral Health Supplements Market Size by Country
- 8.3.1 North America Oral Health Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Oral Health Supplements Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Oral Health Supplements Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Oral Health Supplements Market Size by Type
- 9.1.1 Europe Oral Health Supplements Revenue by Type (2021-2032)
- 9.1.2 Europe Oral Health Supplements Sales by Type (2021-2032)
- 9.1.3 Europe Oral Health Supplements Price by Type (2021-2032)
- 9.2 Europe Oral Health Supplements Market Size by Application
- 9.2.1 Europe Oral Health Supplements Revenue by Application (2021-2032)
- 9.2.2 Europe Oral Health Supplements Sales by Application (2021-2032)
- 9.2.3 Europe Oral Health Supplements Price by Application (2021-2032)
- 9.3 Europe Oral Health Supplements Market Size by Country
- 9.3.1 Europe Oral Health Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Oral Health Supplements Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Oral Health Supplements Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Oral Health Supplements Market Size by Type
- 10.1.1 China Oral Health Supplements Revenue by Type (2021-2032)
- 10.1.2 China Oral Health Supplements Sales by Type (2021-2032)
- 10.1.3 China Oral Health Supplements Price by Type (2021-2032)
- 10.2 China Oral Health Supplements Market Size by Application
- 10.2.1 China Oral Health Supplements Revenue by Application (2021-2032)
- 10.2.2 China Oral Health Supplements Sales by Application (2021-2032)
- 10.2.3 China Oral Health Supplements Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oral Health Supplements Market Size by Type
- 11.1.1 Asia Oral Health Supplements Revenue by Type (2021-2032)
- 11.1.2 Asia Oral Health Supplements Sales by Type (2021-2032)
- 11.1.3 Asia Oral Health Supplements Price by Type (2021-2032)
- 11.2 Asia Oral Health Supplements Market Size by Application
- 11.2.1 Asia Oral Health Supplements Revenue by Application (2021-2032)
- 11.2.2 Asia Oral Health Supplements Sales by Application (2021-2032)
- 11.2.3 Asia Oral Health Supplements Price by Application (2021-2032)
- 11.3 Asia Oral Health Supplements Market Size by Country
- 11.3.1 Asia Oral Health Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Oral Health Supplements Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Oral Health Supplements Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oral Health Supplements Market Size by Type
- 12.1.1 SAMEA Oral Health Supplements Revenue by Type (2021-2032)
- 12.1.2 SAMEA Oral Health Supplements Sales by Type (2021-2032)
- 12.1.3 SAMEA Oral Health Supplements Price by Type (2021-2032)
- 12.2 SAMEA Oral Health Supplements Market Size by Application
- 12.2.1 SAMEA Oral Health Supplements Revenue by Application (2021-2032)
- 12.2.2 SAMEA Oral Health Supplements Sales by Application (2021-2032)
- 12.2.3 SAMEA Oral Health Supplements Price by Application (2021-2032)
- 12.3 SAMEA Oral Health Supplements Market Size by Country
- 12.3.1 SAMEA Oral Health Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Oral Health Supplements Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Oral Health Supplements Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Oral Health Supplements Value Chain Analysis
- 13.1.1 Oral Health Supplements Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oral Health Supplements Production Mode & Process
- 13.2 Oral Health Supplements Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oral Health Supplements Distributors
- 13.2.3 Oral Health Supplements Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst